Skip to content

Home - Media - Press releases    
22 August 2006
AstraZeneca UK Limited Completes Acquisition of Cambridge Antibody Technology Group plc Compulsory Acquisition Procedure Completed Subsequent Offer Period Closed

AstraZeneca today announced that it has completed the compulsory acquisition procedure under the Interim Regulations and now owns 100 percent of the issued share capital of CAT.

The Subsequent Offer Period has now ended and the Offer is closed for further acceptance.
Defined terms used in this announcement have the same meanings as in the Offer Document dated 23 May 2006.

-Ends-

22 August 2006

Enquiries:

AstraZeneca
Media Enquiries:
Steve Brown (London) +44 (0)20 7304 5033
Edel McCaffrey (London) +44 (0) 20 7304 5034
Staffan Ternby (Sweden) +46 8 553 26107

Analyst/Investor Enquiries:
Jonathan Hunt (London) +44 (0) 20 7304 5087
Jörgen Winroth (US) +1 212 579 0506
AstraZeneca websites
Search
 Terms of use  Privacy policy    © AstraZeneca PLC 2003 - 2008